ImmunityBio, Inc. (IBRX)
7.175
+0.26
(+3.68%)
USD |
NASDAQ |
Jun 08, 16:00
7.16
-0.02
(-0.21%)
After-Hours: 20:00
ImmunityBio EPS Diluted (Quarterly) : -0.6162 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sana Biotechnology, Inc. | -0.1705 |
| Erasca, Inc. | -0.6028 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Denali Therapeutics, Inc. | -0.6882 |
| Cogent Biosciences, Inc. | -0.60 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -632.80M |
| Revenue (Quarterly) | 44.21M |
| Total Expenses (Quarterly) | 676.99M |
| Enterprise Value | 7.992B |
| Gross Profit Margin (Quarterly) | 89.55% |
| Profit Margin (Quarterly) | -1.43K% |
| Earnings Yield | -11.90% |
| Normalized Earnings Yield | -7.367 |